首页 | 本学科首页   官方微博 | 高级检索  
检索        

肺表面活性物质治疗足月新生儿肺出血的临床研究
引用本文:潘荣华,张士发,邰海服,胡芳,陈爱斌,茅双根.肺表面活性物质治疗足月新生儿肺出血的临床研究[J].中国临床药理学与治疗学,2014(4):454-458.
作者姓名:潘荣华  张士发  邰海服  胡芳  陈爱斌  茅双根
作者单位:[1]皖南医学院第一附属医院药剂科,安徽芜湖241001 [2]皖南医学院第一附属医院儿科,安徽芜湖241001
基金项目:芜湖市2009年度科技计划重点项目(卫生类-2-7)
摘    要:目的 评价PS在足月新生儿肺出血中的治疗作用。方法 40例肺出血足月新生儿,随机分为组PS组(机械通气+气管内滴注血凝酶和PS)和对照组(机械通气+气管内滴注血凝酶),每组20例,机械通气12 h,行血气分析,同时记录呼吸机的相关参数(RR、Vte、PIP、Pmean、Crs);治愈新生儿肺出血停止平均时间 和撤离呼吸机时间及病死率。结果 PS组治愈18例,死亡2例;对照组治愈17例,死亡3例,病死率(10% vs 15%)较相近(P﹥0.05);PS组肺出血停止和辅助通气时间较对照组明显缩短(43.78±8.14 vs 50.65±7.77,70.56±6.92 vs 76.06±7.29,h)(P﹤0.05);呼吸力学指标PS组PIP和 Pmean 低于对照组(27.72±1.41 vs 28.12±1.27,24.50±1.54 vs 26.06±1.25 , cmH2O)(P﹤0.05),Crs高于对照组(0.85±0.13 vs 0.76±0.09, ml/cmH2O)(P﹤0.05), RR和Vte两组间比较无明显变化(P﹥0.05);两组氧动力学指标PaO2 、SaO2比较变化相近(P﹥0.05),PS组PaO2/ Fi O2高于对照组(234.11±30.14 vs 215.88±14.30)(P﹤0.05)。结论 外源性 PS主要通过改善氧合及呼吸力学效应等机制,有效防治足月新生儿肺出血。

关 键 词:肺表面活性物质  肺出血  足月新生儿

Therapeutic effects of pulmonary surfactant in full term infant with pulmonary hemorrhage
PAN Rong-hua,ZHANG Shi-fa,TAI Hai-fu,HU Fang,CHENG Ai-bin,MAO Shuang-gen.Therapeutic effects of pulmonary surfactant in full term infant with pulmonary hemorrhage[J].Chinese Journal of Clinical Pharmacology and Therapeutics,2014(4):454-458.
Authors:PAN Rong-hua  ZHANG Shi-fa  TAI Hai-fu  HU Fang  CHENG Ai-bin  MAO Shuang-gen
Institution:1.Department of Hospital Pharmacy, 2 Department of Wannan Medical College, Wuhu 241001 ,Anhui,China)
Abstract:AIM: To evaluate the efficacy and safety of the exogenous pulmonary surfactants (PS) in the treatment of full term neonates with pulmonary hemorrhage. METHODS: Forty full- term newborns with pulmonary hemorrhage were equally randomized into PS group (mechan- ical ventilation q-PS and instillation of hemo- eoagulase via endotracheal tube,n=20) and con- trol group(mechanical ventilation + hemocoagu- lase instillation via endotracheal tube, n= 20). The blood was obtained in the two groups via ra- dial artery respectively at 6 , 12 ,24 h after in- tervention for blood gas analysis. Other data were maintained concerning the indexes of re- spiratory mechanics(PIP and Crs), oxygen ki- netic(PaCO2 ,PaO2 and PaOz/FiO2), case fatali- ty rate, mean time for stoppage of pulmonary hemorrhage and withdrawal of the breathing ap- paratus. RESULTS. In PS group, 18 cases were cured and 2 cases died, and in the controls, 17cases were cured and death occurred in 3 cases. The case fatality rate was 10% vs 15% for the two groups, there was no statistically significant difference (P〉0.05). The time for hemorrhage stoppage and withdrawal of the ventilator was significantly reduced in PS group, and the inde- xes of PIP at each time point were lower, where- as the levels of Crs, PaO2 and PaO2/FiO2 were elevated; compared with the controls, there were statistically significant difference ( all P 〈0.05), while there was no statistically signifi- cant difference about the PaO2 at each point (all P〈 0.05) had no difference. CONCLUSION: The exogenous PS is safe and effective in treat- ment of full-term neonates with pulmonary hem-orrhage.
Keywords:pulmonary surfactant  pulmonary hemorrhage  full-term newborn
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号